September 13, 2016: ACTTION Receives Second 5-Year Cooperative Agreement from FDA

ACTTION is very pleased to announce that it has been awarded a second 5 years of funding from the FDA. The award is for up to a maximum of $4,000,000 to support ACTTION’s ongoing and planned efforts to expedite the discovery and development of improved analgesic, anesthetic, addiction, and peripheral neuropathy treatments for the benefit of the public health.

News

ACTTION Guide to Clinical Trials of Pain Treatments

The ACTTION Guide to Clinical Trials of Pain Treatments consists of two supplements published in the journal Pain Reports that include a series of articles describing research designs and methods, study conduct, outcome measures, data analyses and interpretation, and reporting recommendations for clinical trials of acute and chronic pain treatments.

Part I includes 9 articles that can be found here, and Part II includes 6 articles that can be found here.